Cactus Life Sciences Top 5 Trends of 2024

Cactus Life Sciences’ Top 5 Trends of 2024: Insights Driving Tomorrow’s MedComms

Here, we revisit our most thought-provoking articles and whitepapers, each addressing pivotal trends that influence the ever-evolving biopharma landscape...
Read More

Top Stories

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Involve Medical Affairs in insight management, early phases of clinical trials, etc.

It’s Never Too Soon: How and When to

Engagement with Medical Affairs is critical at every...
Leverage Social Media to Transform Medical Affairs | Promoting Disease Awareness, Ensuring Compliance and Assessing Outcomes

Leveraging Social Media to Transform Medical

This whitepaper explores the role of social media in...
    EU MedTech Summit 2020

    EU MedTech Summit 2020: Highlights and Top 3 Takeaways

    How is the MedTech industry gearing up for the EU-MDR? Here are some key takeaways...
    Fireside chat preview: Strategy and leadership in MedTech

    Fireside Chat Preview: Strategy and Leadership in MedTech

    Catch a sneak peek of an engaging fireside chat between Cactus Life Sciences and MedTech...
    A summary of journal articles authored by the Cactus Life Sciences team

    Our Journal Publication Showcase

    A summary of journal articles authored by the Cactus Life Sciences team...
    Trends in publication review of articles

    Review Article Publication Trends

    This poster was presented by representatives from Cactus Life Sciences at the 11th Annual Meeting...
    EU MDR Whitepaper

    EU MDR: Increasing Expectations for Clinical Evidence

    While the global medical devices industry is closely watching how the European Union (EU) Medical...
    A fireside chat on how MedTech leaders are called to respond to EU-MDR

    Fireside Chat Part 1: How MedTech Leaders Are Called to Respond to EU MDR

    A fireside chat on how MedTech leaders are called to respond to EU-MDR...

    Learn more ABOUT our company.